The 2018 ANA Annual Meeting was attended by reporters from across the country representing general news and trade publications, and the groundbreaking research presented at the Meeting was covered by many more. Below are highlights of the ANA2018 media coverage:
HealthDay: Stroke After Heart Attack: Danger May Persist for Months
HealthDay: Gene therapy for Parkinson's disease symptoms shows promise
Clinical Neurology News: Readmission to non-index hospital following acute stroke linked to worse outcomes
Clinical Neurology News: Statins cut all-cause mortality in spinal cord injury
Clinical Neurology News: Study explores link between GERD and poor sleep quality
Clinical Neurology News: High systemic inflammation at midlife portends cognitive changes in later life
Clinical Neurology News: Stroke risk in elderly following AMI extends to 12 weeks
Clinical Neurology News: Investigational gene therapy for medically refractory Parkinson’s shows promise
Neurology Reviews: Many oromandibular dystonia patients report improvement after botulinum toxin injections
Neurology Reviews: Higher BMI associated with greater loss of gray matter volume in MS
Reuters Health: After MI, patients remain at increased risk for ischemic stroke longer than thought
Medscape: Biomarker May Distinguish Parkinson's From MSA
Medscape: Gene Therapy Shows Early Signs of Parkinson's Improvement
Medscape: AD Gene Carriers Show Tau Changes Years Before Symptoms
Medscape: Stroke Risk Increases for 3 Months, Not 1, After MI
Medpage Today: Ebola's Neurological Effects Persist Years After Acute Infection
Medpage Today: Parkinson's Gene Therapy Shows Signs of Motor Improvement
Medpage Today: Ethoxyquin Analogue May Prevent Chemotherapy Nerve Damage
Medpage Today: Blood Biomarker Distinguishes Parkinson's from MSA
Medpage Today: Post-MI Stroke Risk Stays Elevated for Months
Medpage Today: Molecular P-Tau Status May Track Alzheimer Pathology, Symptoms
Neurology Live: ITI-214 Safe With Signs of Efficacy in Phase 1/2 Parkinson Disease Study
Neurology Live: Elizabeth Ross, MD, PhD: Improving the Field By Understanding Mechanisms
Neurology Live: David Holtzman, MD: Difficulties Identifying Dementia With Lewy Bodies
Neurology Live: Anti-CGRP Monoclonal Antibodies Transforming Migraine Treatment
Neurology Live: Joshua Cohen, MD: Fremanezumab for Medication Overuse Headache
Neurology Live: Kate Davis, MD, MSTR: Cognitive Issues In Epilepsy
Neurology Live: Jeff Waugh, MD, PhD: Using Imaging to Discern the Cause of Diseases
Neurology Live: Claire Henchcliffe, MD, DPhil: The History of Stem Cell Therapies for Parkinson Disease
Becker’s Hospital Review: Neurological effects of Ebola remain for up to 3 years after infection